I

Researcher Profile

Ivan Spicka

4

Publications

1,245

Citations

10

Co-Authors

4

Active Years

Publications

Journal Article Blood Nov 03, 2025

Daratumumab monotherapy versus active monitoring in patients with high-risk smoldering multiple myeloma: Aquila outcomes based on mayo 2018/IMWG 2020 risk stratification, IMWG 2020 plus cytogenetic criteria, and age

Peter Voorhees · Meletios Dimopoulos · Yael Cohen · Fredrik Schjesvold +35 more

10.1182/blood-2025-372 2 citations

Journal Article The Lancet Haematology Jun 01, 2022

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios A Dimopoulos · Paul G Richardson · Nizar J Bahlis · Sebastian Grosicki +248 more

10.1016/s2352-3026(22)00103-x 42 citations

Open Access Journal Article Annals of Hematology Jun 25, 2019

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Ivan Spicka · Enrique M. Ocio · Heather E. Oakervee · Richard Greil +17 more

10.1007/s00277-019-03739-2 52 citations

Journal Article New England Journal of Medicine Jan 08, 2015

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

A. Keith Stewart · S. Vincent Rajkumar · Meletios A. Dimopoulos · Tamas Masszi +26 more

10.1056/nejmoa1411321 1,149 citations

Publication Timeline

2025

1

2022

1

2019

1

2015

1

Frequent Co-Authors

María-Victoria Mateos

Antonio Palumbo

Meletios A. Dimopoulos

Dina Ben-Yehuda

S. Vincent Rajkumar